Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.
Press releases published on June 30, 2025
Earn Up to $1,000,000 a Day with BTC Miner – 100% Guaranteed Profits
GlobeNewswire
·
June 30, 2025
London, UK , June 30, 2025 (GLOBE NEWSWIRE) -- - BTC Miner, the official website of the leading provider of cloud mining solutions, today announced the integration of XRP (Ripple) as a supported payment method for its cloud mining contracts. This new …
BTCMiner Enhances The Value of Cloud Mining With Certified Platform and Principal and Interest Guarantee
GlobeNewswire
·
June 30, 2025
London, UK, June 30, 2025 (GLOBE NEWSWIRE) -- BTCMiner, a pioneering smart cloud mining platform founded in 2009, today highlights its robust framework designed to provide secure and stable cryptocurrency mining opportunities. In an era of rapidly changing …
Artelo Biosciences Announces Positive First-in-Human Data for ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
GlobeNewswire
·
June 30, 2025
First Orally Active Fatty Acid Binding Protein 5 Inhibitor Evaluated in Humans First-in-Class Approach Targets Unmet Need in Multibillion-Dollar Pain Management Market SOLANA BEACH, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq …
Topicus.com Inc. successfully completes inaugural €200 million Schuldschein loan
GlobeNewswire
·
June 30, 2025
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (the “Corporation”) (TSXV: TOI) today announced that its subsidiary, Topicus.com Coöperatief U.A., has successfully obtained a €200 million senior unsecured Schuldschein loan. The Schuldschein …
Diginex’s AI-Driven Enhancements Poised to Accelerate Customer Adoption and Drive Revenue Growth
GlobeNewswire
·
June 30, 2025
LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced additional government funding support for its innovative AI-powered compliance …
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
GlobeNewswire
·
June 30, 2025
Global Phase 3 PROMINENT study will evaluate the efficacy and safety of felzartamab, as compared to tacrolimus, in adults with primary membranous nephropathy (PMN) There are currently no therapies specifically approved for PMN, a rare immune-mediated …
Abeona Therapeutics® added to Membership of U.S. Small-cap Russell 2000® Index and Broad-market Russell 3000® Index
GlobeNewswire
·
June 30, 2025
CLEVELAND, June 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it was added as a member of the U.S. small-cap Russell 2000® Index and the broad-market Russell 3000® Index as part of the reconstitution of the …
INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease
GlobeNewswire
·
June 30, 2025
In the Phase 2 MINDFuL trial of XPro™ in patients with early Alzheimer’s Disease (AD) with biomarkers of inflammation, the modified intent-to-treat (mITT) population (n=200) did not meet the primary cognitive endpoint (EMACC), however in a predefined …
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
GlobeNewswire
·
June 30, 2025
Primary objective to determine optimal dosing schedule for a registrational trial Trial builds on recommended Phase 2 dose determined in completed Phase 1 trial Trial benefits from $17.6M award from the Cancer Prevention …
BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty
GlobeNewswire
·
June 30, 2025
BridgeBio has received a $300 million upfront payment, strengthening the Company’s balance sheet, and supporting the launch of Attruby® and ongoing late-stage pipeline programs Transaction monetizes 60% of BridgeBio’s European royalties on the first $500 …
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY HAS BEEN APPROVED TO RECEIVE SCOTT COUNTY OPIOID ABATEMENT FUNDS
GlobeNewswire
·
June 30, 2025
WEST PALM BEACH, FLORIDA, June 30, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has been approved to receive Scott …
Azerion in Discussions Regarding Potential Sale of Whow Games
GlobeNewswire
·
June 30, 2025
Amsterdam, 30 June 2025 - Following a recent media publication, Azerion confirms that it is in discussions with DoubleU Games regarding a potential sale of Whow Games, a part of its Premium Games Segment. As already indicated to the market, Azerion …
Celcuity Reports Clinical Data from Two Early Phase Studies of Gedatolisib
GlobeNewswire
·
June 30, 2025
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plus darolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”), the six-month radiographic progression free survival (“rPFS”) rate was 66% • In a …
For the Second Consecutive Year, HRCI Named a Top Workplaces Award Winner by The Washington Post
GlobeNewswire
·
June 30, 2025
ALEXANDRIA, Va., June 30, 2025 (GLOBE NEWSWIRE) -- HRCI, the premier credentialing and learning community for the human resource profession, has once again been recognized as a Top Workplace by The Washington Post. This list is based solely on employee …
Lantronix Enters Into Cooperation Agreement With Investor Group Led by Chain of Lakes Investment Fund LLC
GlobeNewswire
·
June 30, 2025
IRVINE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX) (the “Company”), a global leader in compute and connectivity IoT solutions enabling Edge AI intelligence, today announced that it has entered into a cooperation agreement with …
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
GlobeNewswire
·
June 30, 2025
Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human safety data from 1,929 patient Phase 3 program AUSTIN, Texas, June 30, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA …
Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
GlobeNewswire
·
June 30, 2025
CHATHAM, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company, today announced that it will be added to the broad-market Russell 3000® Index, with …
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation
GlobeNewswire
·
June 30, 2025
DUBLIN, June 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S. Court of Appeals for the District of …
Zefiro Subsidiary Plants & Goodwin Awarded Additional Government-Funded Remediation Work in Ohio
GlobeNewswire
·
June 30, 2025
Earlier this month, the Company announced that the Ohio Department of Natural Resources awarded Zefiro subsidiary Plants …
Zscaler Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2028
GlobeNewswire
·
June 30, 2025
SAN JOSE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS) today announced that it intends to offer $1.5 billion aggregate principal amount of its convertible senior notes due 2028 (the “notes”) in a private offering to persons …